Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Peter Kalinka

Peter Kalinka

Chairman at Longmore 60 Biotech Inc. Longmore 60 Biotech Inc USA

Sarfaraz Niazi

Sarfaraz Niazi

Chairman Karyo Biologics and Adello Biologics USA

Yashwant Pathak

Yashwant Pathak

Associate Dean University of South Florida Health USA

Francois-Xavier Frapaise

Francois-Xavier Frapaise

Principle FX Frapaise Pharma Consulting France

Pawan Saharan

Pawan Saharan

Founder CEO Biomix Network Ltd India

Rodica Olteanu

Rodica Olteanu

Medical Director Colentina Clinical Hospital Romania

Kurt R Karst

Kurt R Karst

Director Hyman, Phelps & McNamara, PC USA

Fiona M Greer

Fiona M Greer

Director SGS Life Sciences Switzerland

Recommended Global Pharmaceutical Sciences Webinars & Conferences

Europe & UK

Asia Pacific & Middle East

Canada

Pharmacology-2024

About conference

Welcome to the 39th World Congress on Pharmacology and Therapeutics, Pharmacology-2024, slated to convene on November 28-29, 2024, in the enchanting city of Paris, France. With a legacy of three decades in orchestrating impactful gatherings, we are proud to unveil our conference theme: "Artificial Intelligence in Drug Discovery and Development."

As pioneers in the field, we recognize the transformative power of artificial intelligence (AI) in revolutionizing pharmacology and therapeutics. Our esteemed speakers and delegates will delve into cutting-edge research, innovative methodologies, and transformative applications of AI in accelerating drug discovery and development processes.

Pharmacology-2024 is not merely a conference; it's a collaborative platform where luminaries, scholars, practitioners, and industry leaders converge to exchange insights, foster partnerships, and shape the future of pharmacological sciences.

Moreover, we are delighted to announce that Pharmacology-2024 is CME-CPD accredited, ensuring that participants receive the highest quality educational experience while earning valuable credits.

Join us in the vibrant city of Paris, where science, innovation, and culture intertwine, as we embark on a journey to harness the potential of artificial intelligence for the betterment of global healthcare. Let's chart new frontiers and redefine the landscape of pharmacology and therapeutics together at Pharmacology-2024.

Why to Attend

It is with great enthusiasm that I extend this invitation to the prestigious 39th World Congress on Pharmacology and Therapeutics, Pharmacology-2024, set to take place in the breathtaking city of Paris, France, on November 28-29, 2024.

  1. Cutting-edge Insights: Explore the forefront of pharmacological innovation with our conference theme, "Artificial Intelligence in Drug Discovery and Development." Discover how AI is reshaping the landscape of pharmacology, unlocking new possibilities, and accelerating the pace of drug discovery and development.

  2. Networking Opportunities: Connect with leading researchers, practitioners, and industry experts from across the globe. Forge new collaborations, exchange ideas, and cultivate partnerships that will propel your research and career forward.

  3. Professional Growth: Pharmacology-2024 is CME-CPD accredited, ensuring that your participation contributes to your professional development. Earn valuable credits while gaining access to high-quality educational sessions and workshops led by renowned experts in the field.

  4. Immersive Experience: Experience the magic of Paris, a city renowned for its rich history, culture, and culinary delights. Explore iconic landmarks, indulge in gourmet cuisine, and immerse yourself in the vibrant energy of this cultural hub.

  5. Impactful Contributions: Your presence at Pharmacology-2024 will contribute to shaping the future of pharmacology and therapeutics. Share your insights, contribute to meaningful discussions, and be part of the collective effort to advance healthcare through innovation and collaboration.

Join us at Pharmacology-2024 for an unforgettable experience that promises to inspire, educate, and empower. Together, let us chart the course towards a future where AI-driven advancements revolutionize the field of pharmacology for the betterment of society.

Who Can Attend?

The 39th World Congress on Pharmacology and Therapeutics, Pharmacology-2024, promises to be a gathering of minds from diverse backgrounds united by a common passion for advancing the field of pharmacology. 

Here's a brief overview of who can benefit from attending Pharmacology-2024:

  1. Researchers: Whether you're an established researcher or a budding scientist, Pharmacology-2024 offers a platform to showcase your latest findings, exchange insights with peers, and stay updated on the most recent advancements in pharmacological research.

  2. Practitioners: Clinicians, pharmacists, and healthcare professionals will find Pharmacology-2024 invaluable for staying abreast of emerging trends, best practices, and innovative therapies in pharmacology and therapeutics.

  3. Industry Leaders: Pharmaceutical companies, biotech firms, and healthcare technology providers will discover ample opportunities for networking, collaboration, and showcasing their latest products, services, and innovations to a global audience.

  4. Academicians and Educators: Professors, educators, and academic researchers will benefit from Pharmacology-2024's educational sessions, workshops, and discussions, which offer insights into incorporating AI into pharmacology curricula and fostering the next generation of pharmacologists.

  5. Regulatory Authorities: Representatives from regulatory agencies will find Pharmacology-2024 instrumental in staying informed about the latest developments in pharmacological research, ensuring regulatory compliance, and contributing to the safe and effective use of pharmaceuticals.

  6. Students: As the future leaders of pharmacology, students from undergraduate, graduate, and postgraduate programs are encouraged to attend Pharmacology-2024 to gain exposure to cutting-edge research, network with professionals, and explore potential career paths in the field.

Regardless of your professional background or level of expertise, Pharmacology-2024 offers a welcoming and inclusive environment where collaboration, learning, and innovation thrive. Join us in Paris, France, on November 28-29, 2024, for an enriching and inspiring experience at Pharmacology-2024.

Session & Track

  1. Advancements in Drug Discovery: Leading experts share insights into the latest breakthroughs and trends in drug discovery, including novel targets and innovative methodologies.

  2. Biotechnology in Pharmacotherapy: Explore the interface between biotechnology and pharmacology, focusing on biologics, biosimilars, and gene therapies for various diseases.

  3. Pharmacogenetics and Personalized Medicine: Discuss the role of genetics in drug response variability and the application of pharmacogenomics for personalized therapeutic approaches.

  4. Immunopharmacology of Autoimmune Disorders: Examine the immunological basis of autoimmune diseases and novel immunomodulatory therapies for conditions such as rheumatoid arthritis and lupus.

  5. Pharmacology of Rare Diseases: Investigate pharmacological interventions for rare and orphan diseases, including challenges in drug development and regulatory pathways for orphan drug approval.

  6. Pharmacokinetics and Pharmacodynamics: Explore the principles of drug absorption, distribution, metabolism, and excretion, and their impact on drug efficacy and safety.

  7. Digital Health and Pharmacology: Discuss the integration of digital technologies, such as wearable devices and telemedicine, in pharmacological research, patient monitoring, and healthcare delivery.

  8. Pharmacology of Aging and Geriatric Medicine: Address the unique pharmacological considerations in elderly patients, including polypharmacy, drug interactions, and age-related changes in drug metabolism.

  9. Pharmacovigilance in the Era of Big Data: Examine the use of big data analytics and real-world evidence in pharmacovigilance for early detection of drug safety issues and risk management.

  10. Drug Repurposing and Drug Rediscovery: Explore strategies for identifying new therapeutic uses for existing drugs, including computational approaches, high-throughput screening, and phenotypic profiling.

  11. Pharmacology of Addiction and Substance Abuse: Discuss pharmacological treatments for addiction disorders, including opioids, alcohol, nicotine, and emerging substances of abuse.

  12. Pharmacology of Nutraceuticals and Dietary Supplements: Evaluate the pharmacological effects and safety profiles of nutraceuticals and dietary supplements, including herbal remedies and micronutrients.

  13. Pharmacology of Cancer Immunotherapy: Examine the mechanisms of action of immune checkpoint inhibitors, chimeric antigen receptor (CAR) T-cell therapy, and other immunotherapies for cancer treatment.

  14. Pharmacology of Antimicrobial Resistance: Address the global challenge of antimicrobial resistance and strategies for developing novel antibiotics, antimicrobial stewardship, and infection control measures.

  15. Pharmacology of Neurodegenerative Disorders: Investigate the underlying pathophysiology of neurodegenerative diseases, such as Alzheimer's and Parkinson's, and potential pharmacological interventions.

  16. Pharmacology of Pain Management and Analgesia: Explore novel targets and therapeutic approaches for managing acute and chronic pain conditions, including opioid alternatives and non-pharmacological interventions.

  17. Pharmacology of Cardiovascular Therapeutics: Discuss the latest advancements in cardiovascular pharmacotherapy, including anticoagulants, antiarrhythmics, and drugs for heart failure management.

  18. Pharmacology of Endocrine Disorders: Address the pharmacological management of endocrine disorders, including diabetes, thyroid disorders, and hormonal imbalances.

  19. Pharmacology of Respiratory Diseases: Examine pharmacological treatments for respiratory conditions, such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis.

  20. Ethical Considerations in Pharmacological Research and Clinical Trials: Reflect on ethical issues in pharmacological research, including informed consent, patient privacy, and conflicts of interest in clinical trials.

These Session & Track topics cover a broad spectrum of contemporary issues and emerging trends in pharmacology and therapeutics, providing attendees with valuable insights and opportunities for collaboration and knowledge exchange.

Participant Options & Benefits

  1. Delegate Registration: By registering as a delegate, you gain access to all sessions, workshops, and networking opportunities offered at the Congress. Engage with leading experts, present your research findings, and participate in discussions that shape the future of pharmacology and therapeutics.

  2. Presenter Opportunities: Share your latest research findings, innovations, and case studies by presenting a paper, poster, or oral presentation at the Congress. Gain recognition for your work, receive valuable feedback from peers, and contribute to advancing the field of pharmacology.

  3. Networking: Forge meaningful connections with fellow participants, including researchers, practitioners, industry professionals, and policymakers. Exchange ideas, collaborate on projects, and establish partnerships that transcend geographical boundaries and disciplines.

  4. Educational Sessions: Benefit from educational sessions led by renowned experts in pharmacology and therapeutics. Gain insights into emerging trends, best practices, and innovative approaches in drug discovery, development, and clinical practice.

  5. CME-CPD Accreditation: Earn continuing medical education (CME) or continuing professional development (CPD) credits by attending accredited sessions at the Congress. Enhance your professional development, maintain licensure, and stay updated on the latest advancements in pharmacological sciences.

  6. Exhibition and Sponsorship Opportunities: Showcase your products, services, and innovations to a global audience of industry professionals, researchers, and decision-makers by participating as an exhibitor or sponsor. Increase brand visibility, generate leads, and network with key stakeholders in the field.

  7. Access to Virtual Platform: For participants unable to attend in person, we offer access to a virtual platform that provides live streaming of sessions, virtual networking opportunities, and on-demand content. Experience the Congress from anywhere in the world, without missing out on valuable insights and interactions.

  8. Certificate of Participation: Upon completion of the Congress, all participants will receive a certificate of participation, acknowledging their contribution to the success of the event and their commitment to advancing pharmacological sciences.

We are committed to ensuring that your participation in the 39th World Congress on Pharmacology and Therapeutics is both rewarding and impactful. Join us in Paris, France, or virtually, on November 28-29, 2024, for an enriching experience that will shape the future of pharmacology and therapeutics.

Market Analysis

As a seasoned marketing expert with three decades of experience, I've conducted a comprehensive market analysis focusing on the pharmacology and therapeutics sector from 2022 to 2024. During this period, the pharmaceutical market in Europe has witnessed significant growth, with projected revenue reaching US$194.90 billion by 2024. This growth is driven by several factors, including increasing healthcare expenditures, advancements in drug development technologies, and rising demand for innovative therapies.

One of the key segments driving this growth is oncology drugs, which is projected to have a market volume of US$37.80 billion in 2024. The increasing incidence of cancer, coupled with advancements in cancer treatment modalities such as targeted therapies and immunotherapy, has fueled the demand for oncology drugs. Pharmaceutical companies are investing heavily in research and development to bring new and effective cancer treatments to market, contributing to the overall growth of the pharmacology and therapeutics sector.

Additionally, other therapeutic areas such as cardiovascular diseases, neurology, infectious diseases, and metabolic disorders continue to represent significant market opportunities. The introduction of novel drugs targeting these conditions, along with the adoption of precision medicine and personalized therapies, further contributes to market expansion.

Furthermore, the regulatory landscape remains a critical factor influencing market dynamics. Regulatory agencies such as the European Medicines Agency (EMA) play a pivotal role in ensuring the safety, efficacy, and quality of pharmaceutical products, thereby shaping market trends and driving industry compliance.

Looking ahead, the pharmacology and therapeutics market is expected to continue its growth trajectory, fueled by ongoing research and development efforts, advancements in technology, and evolving healthcare needs. Understanding these market trends and dynamics is essential for pharmaceutical companies to capitalize on opportunities and navigate challenges in this dynamic and competitive landscape.

 

To Collaborate Scientific Professionals around the World

Conference Date November 28-29, 2024

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Supported By

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by